Key Points
- CEO Kevin Yeaman sold 36,699 shares at an average price of $66.91 for about $2.46 million, reducing his stake by 24.24% to 114,725 shares (valued at roughly $7.68 million).
- Dolby beat Q2 estimates, reporting $0.99 EPS versus a $0.70 consensus and $307.0 million in revenue, and set FY2026 guidance of $4.19–$4.34 EPS.
- Dividend increased to $0.36 per share quarterly (from $0.33), an annualized $1.44 with a 2.1% yield; the ex-dividend date is Dec. 2 and the payment date is Dec. 10.
Dolby Laboratories (NYSE:DLB - Get Free Report) CEO Kevin Yeaman sold 36,699 shares of Dolby Laboratories stock in a transaction dated Monday, November 24th. The shares were sold at an average price of $66.91, for a total value of $2,455,530.09. Following the transaction, the chief executive officer owned 114,725 shares of the company's stock, valued at $7,676,249.75. The trade was a 24.24% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.
Dolby Laboratories Trading Down 0.5%
Shares of DLB stock opened at $67.07 on Thursday. The stock has a market cap of $6.43 billion, a P/E ratio of 24.57 and a beta of 0.97. Dolby Laboratories has a twelve month low of $64.02 and a twelve month high of $89.66. The stock has a 50 day moving average of $68.31 and a 200 day moving average of $72.19.
Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its earnings results on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.70 by $0.29. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The firm had revenue of $307.02 million during the quarter, compared to analyst estimates of $305.76 million. During the same period in the previous year, the firm earned $0.61 EPS. The business's quarterly revenue was up .7% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS. Q1 2026 guidance at 0.790-0.940 EPS. On average, research analysts predict that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.
Dolby Laboratories Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 10th. Stockholders of record on Tuesday, December 2nd will be paid a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 2.1%. The ex-dividend date of this dividend is Tuesday, December 2nd. This is an increase from Dolby Laboratories's previous quarterly dividend of $0.33. Dolby Laboratories's dividend payout ratio is currently 54.75%.
Hedge Funds Weigh In On Dolby Laboratories
Institutional investors have recently bought and sold shares of the company. Advisory Services Network LLC acquired a new position in Dolby Laboratories in the 3rd quarter valued at about $102,000. XTX Topco Ltd purchased a new position in Dolby Laboratories in the third quarter worth approximately $741,000. Verition Fund Management LLC grew its position in Dolby Laboratories by 172.4% in the third quarter. Verition Fund Management LLC now owns 35,409 shares of the electronics maker's stock worth $2,563,000 after acquiring an additional 22,409 shares during the period. Qube Research & Technologies Ltd increased its stake in Dolby Laboratories by 5.4% during the third quarter. Qube Research & Technologies Ltd now owns 474,159 shares of the electronics maker's stock worth $34,315,000 after acquiring an additional 24,506 shares during the last quarter. Finally, Mercer Global Advisors Inc. ADV raised its position in Dolby Laboratories by 217.8% in the third quarter. Mercer Global Advisors Inc. ADV now owns 14,567 shares of the electronics maker's stock valued at $1,054,000 after purchasing an additional 9,984 shares during the period. 58.56% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of equities analysts have issued reports on DLB shares. Tigress Financial increased their price target on Dolby Laboratories from $112.00 to $114.00 and gave the stock a "buy" rating in a research report on Friday, August 15th. Weiss Ratings reiterated a "hold (c-)" rating on shares of Dolby Laboratories in a report on Thursday, November 13th. Barrington Research reduced their target price on Dolby Laboratories from $100.00 to $95.00 and set an "outperform" rating for the company in a report on Wednesday, November 19th. Robert W. Baird began coverage on Dolby Laboratories in a research note on Friday, September 5th. They issued a "neutral" rating and a $74.00 price target on the stock. Finally, Baird R W upgraded Dolby Laboratories to a "hold" rating in a research report on Friday, September 5th. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $92.00.
View Our Latest Stock Analysis on DLB
About Dolby Laboratories
(
Get Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
